#623495
2,2'-Déchlóra-4,4'-meitiléindé-aimín
2,2'-Dichloro-4,4'-methylenedianiline
2,2'-Déchlóra-4,4'-meitiléindé-aimín
2,2'-Dichloro-4,4'-methylenedianiline
4,4'-Mheitiléindi-ainilín (MDA); agus tríchlóireitiléin (TCE).
4,4'-Methylenedianiline (MDA) and trichloroethylene (TCE).
4,4'-Mheitiléindi-ainilín
4,4'-Methylenedianiline
Is féidir, ar bhonn na faisnéise atá ar fáil, lena náirítear faisnéis eolaíoch agus theicniúil, teorainnluach a shocrú do 4,4'-Mheitiléindi-ainilín.
It is possible, on the basis of available information, including scientific and technical data, to set a limit value for 4,4'-Methylenedianiline.
(8)Sásaíonn 4,4'-Mheitiléindi-ainilín (MDA) na critéir lena chur in aicme charcanaigineach (catagóir 1B) i gcomhréir le Rialachán (CE) Uimh. 1272/2008 agus dá bhrí sin is carcanaigin é de réir mar atá sainmhínithe i dTreoir 2004/37/CE.
(8)4,4'-Methylenedianiline (MDA) meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore is a carcinogen as defined in Directive 2004/37/EC.
Is iomchuí dá bhrí sin teorainnluach a bhunú do 4,4'-Mheitiléindi-ainilín i gCuid A d’Iarscríbhinn III agus nodaireacht chraicinn a leagan amach i gCuid B d’Iarscríbhinn III a ghabhann le Treoir 2004/37/CE ina léirítear an fhéidearthacht do thógáil shuntasach dheirmeach.
It is therefore appropriate to establish a limit value in Part A of Annex III for 4,4'-Methylenedianiline and to set out a skin notation in Part B of Annex III to Directive 2004/37/EC indicating the possibility of significant dermal uptake.
(23).Maidir le déchlóiríd eitiléine, úsáidtear breis agus 95% den mhéid iomlán ar an láthair i sintéis chlóreitiléine; Úsáidtear 4,4'-Mheitiléindi-ainilín (99%) mar idirmheánach chun 4,4'-déisicianáit défheinile mheitiléine (MDI) a tháirgeadh; a úsáidtear i dtáirgeadh cúir polúireatáin; Úsáideadh tuairim is 75% de tháirgeadh iomlán tríchlóireitiléine i bhfeidhmeanna idirmheánacha, faoi mar a measadh i staidéar IOM.
In the case of ethylene dichloride, more than 95% of the total volume is use as an intermediate on site in the synthesis of vinyl chloride monomer; 4,4'-Methylenedianiline is mostly (99%) used as an intermediate in the production of 4,4'-methylenediphenyldiisocyanate (MDI), which is used in the production of polyurethane foams; approximately 75% of the total production of trichloroethylene, as assessed in the IOM Study, was used in intermediate applications.